Enabling low cost biopharmaceuticals

A systematic approach to delete proteases from a well-known protein production host trichoderma reesei

Christopher P. Landowski, Anne Huuskonen, Ramon Wahl, Ann Westerholm-Parvinen, Anne Kanerva, Anna-Liisa Hänninen, Noora Salovuori, Merja Penttilä, Jari Natunen, Christian Ostermeier, Bernhard Helk, Juhani Saarinen, Markku Saloheimo

Research output: Contribution to journalArticleScientificpeer-review

21 Citations (Scopus)

Abstract

The filamentous fungus Trichoderma reesei has tremendous capability to secrete proteins. Therefore, it would be an excellent host for producing high levels of therapeutic proteins at low cost. Developing a filamentous fungus to produce sensitive therapeutic proteins requires that protease secretion is drastically reduced. We have identified 13 major secreted proteases that are related to degradation of therapeutic antibodies, interferon alpha 2b, and insulin like growth factor. The major proteases observed were aspartic, glutamic, subtilisin-like, and trypsin-like proteases. The seven most problematic proteases were sequentially removed from a strain to develop it for producing therapeutic proteins. After this the protease activity in the supernatant was dramatically reduced down to 4% of the original level based upon a casein substrate. When antibody was incubated in the six protease deletion strain supernatant, the heavy chain remained fully intact and no degradation products were observed. Interferon alpha 2b and insulin like growth factor were less stable in the same supernatant, but full length proteins remained when incubated overnight, in contrast to the original strain. As additional benefits, the multiple protease deletions have led to faster strain growth and higher levels of total protein in the culture supernatant.
Original languageEnglish
Article numbere0134723
JournalPLoS ONE
Volume10
Issue number8
DOIs
Publication statusPublished - 2015
MoE publication typeA1 Journal article-refereed

Fingerprint

biopharmaceuticals
Trichoderma reesei
Trichoderma
Peptide Hydrolases
proteinases
Costs and Cost Analysis
interferon alfa-2b
Costs
Proteins
proteins
interferon-alpha
somatomedins
Somatomedins
Fungi
Subtilisin
Degradation
fungi
antibodies
degradation
subtilisin

Cite this

Landowski, Christopher P. ; Huuskonen, Anne ; Wahl, Ramon ; Westerholm-Parvinen, Ann ; Kanerva, Anne ; Hänninen, Anna-Liisa ; Salovuori, Noora ; Penttilä, Merja ; Natunen, Jari ; Ostermeier, Christian ; Helk, Bernhard ; Saarinen, Juhani ; Saloheimo, Markku. / Enabling low cost biopharmaceuticals : A systematic approach to delete proteases from a well-known protein production host trichoderma reesei. In: PLoS ONE. 2015 ; Vol. 10, No. 8.
@article{0083164985a0432e8a7ed93a48caa7d2,
title = "Enabling low cost biopharmaceuticals: A systematic approach to delete proteases from a well-known protein production host trichoderma reesei",
abstract = "The filamentous fungus Trichoderma reesei has tremendous capability to secrete proteins. Therefore, it would be an excellent host for producing high levels of therapeutic proteins at low cost. Developing a filamentous fungus to produce sensitive therapeutic proteins requires that protease secretion is drastically reduced. We have identified 13 major secreted proteases that are related to degradation of therapeutic antibodies, interferon alpha 2b, and insulin like growth factor. The major proteases observed were aspartic, glutamic, subtilisin-like, and trypsin-like proteases. The seven most problematic proteases were sequentially removed from a strain to develop it for producing therapeutic proteins. After this the protease activity in the supernatant was dramatically reduced down to 4{\%} of the original level based upon a casein substrate. When antibody was incubated in the six protease deletion strain supernatant, the heavy chain remained fully intact and no degradation products were observed. Interferon alpha 2b and insulin like growth factor were less stable in the same supernatant, but full length proteins remained when incubated overnight, in contrast to the original strain. As additional benefits, the multiple protease deletions have led to faster strain growth and higher levels of total protein in the culture supernatant.",
author = "Landowski, {Christopher P.} and Anne Huuskonen and Ramon Wahl and Ann Westerholm-Parvinen and Anne Kanerva and Anna-Liisa H{\"a}nninen and Noora Salovuori and Merja Penttil{\"a} and Jari Natunen and Christian Ostermeier and Bernhard Helk and Juhani Saarinen and Markku Saloheimo",
year = "2015",
doi = "10.1371/journal.pone.0134723",
language = "English",
volume = "10",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

Enabling low cost biopharmaceuticals : A systematic approach to delete proteases from a well-known protein production host trichoderma reesei. / Landowski, Christopher P.; Huuskonen, Anne; Wahl, Ramon; Westerholm-Parvinen, Ann; Kanerva, Anne; Hänninen, Anna-Liisa; Salovuori, Noora; Penttilä, Merja; Natunen, Jari; Ostermeier, Christian; Helk, Bernhard; Saarinen, Juhani; Saloheimo, Markku.

In: PLoS ONE, Vol. 10, No. 8, e0134723, 2015.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Enabling low cost biopharmaceuticals

T2 - A systematic approach to delete proteases from a well-known protein production host trichoderma reesei

AU - Landowski, Christopher P.

AU - Huuskonen, Anne

AU - Wahl, Ramon

AU - Westerholm-Parvinen, Ann

AU - Kanerva, Anne

AU - Hänninen, Anna-Liisa

AU - Salovuori, Noora

AU - Penttilä, Merja

AU - Natunen, Jari

AU - Ostermeier, Christian

AU - Helk, Bernhard

AU - Saarinen, Juhani

AU - Saloheimo, Markku

PY - 2015

Y1 - 2015

N2 - The filamentous fungus Trichoderma reesei has tremendous capability to secrete proteins. Therefore, it would be an excellent host for producing high levels of therapeutic proteins at low cost. Developing a filamentous fungus to produce sensitive therapeutic proteins requires that protease secretion is drastically reduced. We have identified 13 major secreted proteases that are related to degradation of therapeutic antibodies, interferon alpha 2b, and insulin like growth factor. The major proteases observed were aspartic, glutamic, subtilisin-like, and trypsin-like proteases. The seven most problematic proteases were sequentially removed from a strain to develop it for producing therapeutic proteins. After this the protease activity in the supernatant was dramatically reduced down to 4% of the original level based upon a casein substrate. When antibody was incubated in the six protease deletion strain supernatant, the heavy chain remained fully intact and no degradation products were observed. Interferon alpha 2b and insulin like growth factor were less stable in the same supernatant, but full length proteins remained when incubated overnight, in contrast to the original strain. As additional benefits, the multiple protease deletions have led to faster strain growth and higher levels of total protein in the culture supernatant.

AB - The filamentous fungus Trichoderma reesei has tremendous capability to secrete proteins. Therefore, it would be an excellent host for producing high levels of therapeutic proteins at low cost. Developing a filamentous fungus to produce sensitive therapeutic proteins requires that protease secretion is drastically reduced. We have identified 13 major secreted proteases that are related to degradation of therapeutic antibodies, interferon alpha 2b, and insulin like growth factor. The major proteases observed were aspartic, glutamic, subtilisin-like, and trypsin-like proteases. The seven most problematic proteases were sequentially removed from a strain to develop it for producing therapeutic proteins. After this the protease activity in the supernatant was dramatically reduced down to 4% of the original level based upon a casein substrate. When antibody was incubated in the six protease deletion strain supernatant, the heavy chain remained fully intact and no degradation products were observed. Interferon alpha 2b and insulin like growth factor were less stable in the same supernatant, but full length proteins remained when incubated overnight, in contrast to the original strain. As additional benefits, the multiple protease deletions have led to faster strain growth and higher levels of total protein in the culture supernatant.

U2 - 10.1371/journal.pone.0134723

DO - 10.1371/journal.pone.0134723

M3 - Article

VL - 10

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 8

M1 - e0134723

ER -